Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
1 | 39970990 | 0 | Underwood M, Da Veiga Leprevost F, Basrur V, et al. Identification of multiple novel procoagulant plasma ligands for stabilin-2. J Thromb Haemost. 2025 Feb 17:S1538-7836(25)00106-0. doi: 10.1016/j.jtha.2025.01.023. |
2 | 39642092 | 0 | Albisetti M, Ardila J, Astermark J, et al. International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical Appraisal. Haemophilia. 2024 Dec 6. doi: 10.1111/hae.15135. |
3 | 38381848 | 0 | Strilchuk AW, Hur WS, Batty P, et al. Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A. Sci Transl Med. 2024 Feb 21;16(735):eadh0027. doi: 10.1126/scitranslmed.adh0027. Epub 2024 Feb 21. |
4 | 37085036 | 0 | Swystun LL, Michels A, Lillicrap D. The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF-FVIII clearance in thrombosis and hemostasis. J Thromb Haemost. 2023 Apr 19:S1538-7836(23)00332-X. doi: 10.1016/j.jtha.2023.04.014. |
5 | 36696220 | 0 | Choi SJ, Dwyer CN, Rapkin L, et al. The mechanistic and structural role of von Willebrand factor in endotoxemia-enhanced deep vein thrombosis in mice. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)07636-X. doi: 10.1016/j.jtha.2022.11.022. |
6 | 35780487 | 0 | Lavin M, Christopherson P, Grabell J, et al. Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding score. J Thromb Haemost. 2022 Jul 3. doi: 10.1111/jth.15807. |
7 | 35445575 | 0 | Lillicrap D, Morrissey JH. Investment in the future of thrombosis and hemostasis science. J Thromb Haemost. 2022 May;20(5):1033. doi: 10.1111/jth.15710. |
8 | 35028601 | 0 | Michels A, Lillicrap D, Yacob M. Role of von Willebrand factor in venous thromboembolic disease. JVS Vasc Sci. 2021 Oct 7;3:17-29. doi: 10.1016/j.jvssci.2021.08.002. eCollection 2022. |
9 | 34649864 | 0 | Sholzberg M, Tang GH, Rahhal H, et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400. |
10 | 34351057 | 0 | Othman M, Baker AT, Gupalo E, et al. To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia. J Thromb Haemost. 2021 Nov;19(11):2845-2856. doi: 10.1111/jth.15485. Epub 2021 Aug 23. |